StockMacro
Company, fund or insider

Help

Menu

Intensity Therapeutics

$2.48 -47% in 6 monthsMarket cap $8.2M

INTS on XNAS, Health Care, Intensity Therapeutics, Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 74% in a year while net loss reached $12M against $8.5M cash.

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
7
Website
intensitytherapeutics.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 4 Mar 2027 (an estimate: a year ago it reported on 5 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $3.5M.
Quarter to 30 Jun 2022: revenue –, net income -$1.9MQuarter to 30 Sep 2022: revenue –, net income -$1.8MQuarter to 31 Dec 2022: revenue –, net income -$1.5MQuarter to 31 Mar 2023: revenue –, net income -$1.3MQuarter to 30 Jun 2023: revenue –, net income -$3.7MQuarter to 30 Sep 2023: revenue –, net income -$2.3MQuarter to 31 Dec 2023: revenue –, net income -$3.2MQuarter to 31 Mar 2024: revenue –, net income -$4.6MQuarter to 30 Jun 2024: revenue –, net income -$5.0MQuarter to 30 Sep 2024: revenue –, net income -$3.5MQuarter to 31 Dec 2024: revenue –, net income -$3.2MQuarter to 31 Mar 2025: revenue –, net income -$3.3MQuarter to 30 Jun 2025: revenue –, net income -$2.5MQuarter to 30 Sep 2025: revenue –, net income -$2.7MQuarter to 31 Dec 2025: revenue –, net income -$3.1MQuarter to 31 Mar 2026: revenue –, net income -$2.4MQuarter to 30 Jun 2026: revenue –, net income -$3.0MQuarter to 30 Sep 2026: revenue –, net income -$3.5M
30 Jun 2022RevenueNet incomeNet losstallest bar $5.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$3.5M
30 Jun 2026–-$3.0M
31 Mar 2026–-$2.4M
31 Dec 2025–-$3.1M
30 Sep 2025–-$2.7M
30 Jun 2025–-$2.5M
31 Mar 2025–-$3.3M
31 Dec 2024–-$3.2M
30 Sep 2024–-$3.5M
30 Jun 2024–-$5.0M
31 Mar 2024–-$4.6M
31 Dec 2023–-$3.2M
30 Sep 2023–-$2.3M
30 Jun 2023–-$3.7M
31 Mar 2023–-$1.3M
31 Dec 2022–-$1.5M
30 Sep 2022–-$1.8M
30 Jun 2022–-$1.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$12.0M -$11.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -162% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $8.5M $7.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$8.5M (net cash) -$7.1M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.32
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.1 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Intensity TherapeuticsINTS (this company) $8.2Mloss–––
IN8bioINAB $8.2Mloss–––
Black Hawk AcquisitionBKHA $7.7M5.9–––
Aligos TherapeuticsALGS $7.6Mloss1.3+122%–
Jasper TherapeuticsJSPR $9.6Mloss–––
aTyr PharmaATYR $9.7Mloss–––

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

26%

874K shares held by 13F filers (30 Sep 2026) of 3.3M outstanding (4 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.3%

76K shares sold short (30 Oct 2026) of 3.3M outstanding (4 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.2

76K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-14%

88K shares sold short in the report before, 76K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

29%

29% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 50%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

6 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $2.48 on 20 Nov 2026, -74% over 12 months (12-month range $2.48 to $14.75)

  • Sharp change
  • 8-K and other filings
Institutional holders (13F filers). 15 13F filers reported holding it in the latest 13F quarter, -40% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: insider net buying (open market), h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
30 Dec 2025Sharp changeShort interest spike: short interest spike, 2.9M vs usual 321K (2025-12-15); 47.4x the same period a year earlier
16 Dec 2025Sharp changeShort interest spike: short interest spike, 2.5M vs usual 215K (2025-11-28); 64.8x the same period a year earlier
5 Dec 20258-K and other filingsDelisting notice or listing transfer
2 Dec 2025Sharp changeShort interest spike: short interest spike, 3.6M vs usual 166K (2025-11-14); 83.0x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 16.8M vs usual 110K (2025-10-31); 378.7x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 2.3M vs usual 61K (2025-10-15); 54.8x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 866K vs usual 58K (2025-09-30); 28.6x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 671K vs usual 52K (2025-08-29); 30.0x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 988K vs usual 52K (2025-08-15); 49.8x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 945K vs usual 52K (2025-07-31); 16.6x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 660K vs usual 44K (2025-06-13); 20.1x the same period a year earlier
6 Jun 20258-K and other filingsDelisting notice or listing transfer
20 May 20258-K and other filingsDelisting notice or listing transfer
24 Apr 20258-K and other filingsRegistered new securities for sale (S-1)
22 Apr 20258-K and other filingsRegistered new securities for sale (S-1)
13 Dec 20248-K and other filingsRegistered new securities for sale (S-1)
5 Dec 20248-K and other filingsPrivate placement of securities (Form D)
23 Oct 20248-K and other filingsDirector or officer change
23 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Jul 20248-K and other filingsDirector or officer change
24 May 20248-K and other filingsDirector or officer change
15 May 20248-K and other filingsDirector or officer change
15 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Apr 20248-K and other filingsDelisting notice or listing transfer
7 Feb 20248-K and other filingsDirector or officer change
12 Dec 20238-K and other filingsDirector or officer change
12 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Jun 20238-K and other filingsRegistered new securities for sale (S-1)
23 Jun 20238-K and other filingsRegistered new securities for sale (S-1)
9 Jun 20238-K and other filingsRegistered new securities for sale (S-1)
18 May 20238-K and other filingsRegistered new securities for sale (S-1)
27 Jan 20238-K and other filingsRegistered new securities for sale (S-1)
13 Jan 20238-K and other filingsRegistered new securities for sale (S-1)
2 Nov 20228-K and other filingsRegistered new securities for sale (S-1)
3 Oct 20228-K and other filingsRegistered new securities for sale (S-1)
20 Sep 20228-K and other filingsRegistered new securities for sale (S-1)
16 May 20228-K and other filingsRegistered new securities for sale (S-1)
19 Apr 20228-K and other filingsRegistered new securities for sale (S-1)
7 Jan 20228-K and other filingsRegistered new securities for sale (S-1)
9 Dec 20218-K and other filingsRegistered new securities for sale (S-1)
8 Dec 20218-K and other filingsRegistered new securities for sale (S-1)
Institutional holders (13F filers)
30 Jun 2023 report: 2; public on 14 Aug 2023
30 Sep 2023 report: 9; public on 14 Nov 2023
31 Dec 2023 report: 17; public on 14 Feb 2024
31 Mar 2024 report: 18; public on 15 May 2024
30 Jun 2024 report: 23; public on 14 Aug 2024
30 Sep 2024 report: 20; public on 14 Nov 2024
31 Dec 2024 report: 19; public on 14 Feb 2025
31 Mar 2025 report: 21; public on 15 May 2025
30 Jun 2025 report: 25; public on 14 Aug 2025
30 Sep 2025 report: 25; public on 14 Nov 2025
31 Dec 2025 report: 31; public on 17 Feb 2026
31 Mar 2026 report: 12; public on 15 May 2026
30 Jun 2026 report: 17; public on 14 Aug 2026
30 Sep 2026 report: 15; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is diluted earnings per share, fiscal year at -$8.6 (31 Dec 2025), 520% below its normal quarter of -$1.4; higher than 25% of its own history.
  • Institutional holders (13F filers): 15 13F filers reported holding it in the latest 13F quarter, -40% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

15 institutions reported shares at the end of Q3 2026, 26% of the shares outstanding; 2 opened a position, 5 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Kingsbury Capital Investment Advisors LLC707K21.4%$2.4M+210K+42%
Rothschild Wealth LLC29K0.89%$98K+2,496+9.3%
Vanguard Capital Management LLC27K0.80%$90KNo change
Nano Cap New Millennium Growth Fund L P25K0.76%$84KNo change
Geode Capital Management, LLC22K0.67%$75K-549-2.4%
Vanguard Fiduciary Trust Co21K0.64%$71K+12K+131%
FNY Investment Advisers, LLC16K0.48%-6,202-28%
Mesirow Financial Investment Management, Inc.14K0.43%$47K-78-0.6%
State Street Corp11K0.32%$36KNew+11K
NewEdge Advisors, LLC1,1480.03%$4KNo change

Company events

All 38 company events

In 12 months: 1 delisting notice. Results releases and routine reports are left out.

FiledWhat happenedSource
5 Dec 2025Delisting notice or listing transfer8-K
31 Oct 2025Signed a major agreement8-K
13 Jun 2025Signed a major agreementSame filing: sold shares privately8-K
6 Jun 2025Delisting notice or listing transfer8-K
20 May 2025Delisting notice or listing transfer8-K
25 Apr 2025Signed a major agreement8-K
24 Apr 2025Registered new securities for sale (S-1)S-1/A
22 Apr 2025Registered new securities for sale (S-1)S-1

The 5 newest of 43 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 25 Dec 2025Short interest and volume change

    had 2.9M shares sold short in the 15 Dec 2025 report, 47× the same report last year.

    Same report last year: 62K; its normal report is 321K.

    See the evidence
    This period
    2.9M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    321K
    Typical spread (median absolute deviation)
    270K
    How far from its usual level
    +6.6
    Same report last year
    62K
    History used
    885 days
    2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K2025-10-15: 2.3M2025-10-31: 16.8M2025-11-14: 3.6M2025-11-28: 2.5M2025-12-15: 2.9M
    the 15 Dec 2025 report24 earlier reportsnormal: 321K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 10 Dec 2025Short interest and volume change

    had 2.5M shares sold short in the 28 Nov 2025 report, 65× the same report last year.

    Same report last year: 39K; its normal report is 215K.

    See the evidence
    This period
    2.5M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    215K
    Typical spread (median absolute deviation)
    174K
    How far from its usual level
    +8.9
    Same report last year
    39K
    History used
    868 days
    2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K2025-10-15: 2.3M2025-10-31: 16.8M2025-11-14: 3.6M2025-11-28: 2.5M
    the 28 Nov 2025 report24 earlier reportsnormal: 215K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 5 Dec 2025Filings record

    Delisting notice or listing transfer

  4. 26 Nov 2025Short interest and volume change

    had 3.6M shares sold short in the 14 Nov 2025 report, 83× the same report last year.

    Same report last year: 43K; its normal report is 166K.

    See the evidence
    This period
    3.6M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    166K
    Typical spread (median absolute deviation)
    126K
    How far from its usual level
    +18.3
    Same report last year
    43K
    History used
    854 days
    2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K2025-10-15: 2.3M2025-10-31: 16.8M2025-11-14: 3.6M
    the 14 Nov 2025 report24 earlier reportsnormal: 166K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 13 Nov 2025Short interest and volume change

    had 16.8M shares sold short in the 31 Oct 2025 report, 379× the same report last year.

    Same report last year: 44K; its normal report is 110K.

    See the evidence
    This period
    16.8M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    110K
    Typical spread (median absolute deviation)
    70K
    How far from its usual level
    +161.2
    Same report last year
    44K
    History used
    840 days
    2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K2025-10-15: 2.3M2025-10-31: 16.8M
    the 31 Oct 2025 report24 earlier reportsnormal: 110K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 25 Oct 2025Short interest and volume change

    had 2.3M shares sold short in the 15 Oct 2025 report, 55× the same report last year.

    Same report last year: 41K; its normal report is 61K.

    See the evidence
    This period
    2.3M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    61K
    Typical spread (median absolute deviation)
    22K
    How far from its usual level
    +43.9
    Same report last year
    41K
    History used
    824 days
    2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K2025-10-15: 2.3M
    the 15 Oct 2025 report24 earlier reportsnormal: 61K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 10 Oct 2025Short interest and volume change

    had 866K shares sold short in the 30 Sep 2025 report, 29× the same report last year.

    Same report last year: 30K; its normal report is 58K.

    See the evidence
    This period
    866K (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    58K
    Typical spread (median absolute deviation)
    20K
    How far from its usual level
    +16.2
    Same report last year
    30K
    History used
    809 days
    2024-09-30: 30K2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K2025-09-15: 254K2025-09-30: 866K
    the 30 Sep 2025 report24 earlier reportsnormal: 58K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 11 Sep 2025Short interest and volume change

    had 671K shares sold short in the 29 Aug 2025 report, 30× the same report last year.

    Same report last year: 22K; its normal report is 52K.

    See the evidence
    This period
    671K (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    52K
    Typical spread (median absolute deviation)
    14K
    How far from its usual level
    +12.4
    Same report last year
    22K
    History used
    777 days
    2024-08-30: 22K2024-09-13: 27K2024-09-30: 30K2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K2025-08-29: 671K
    the 29 Aug 2025 report24 earlier reportsnormal: 52K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 27 Aug 2025Short interest and volume change

    had 988K shares sold short in the 15 Aug 2025 report, 50× the same report last year.

    Same report last year: 20K; its normal report is 52K.

    See the evidence
    This period
    988K (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    52K
    Typical spread (median absolute deviation)
    13K
    How far from its usual level
    +18.7
    Same report last year
    20K
    History used
    763 days
    2024-08-15: 20K2024-08-30: 22K2024-09-13: 27K2024-09-30: 30K2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K2025-08-15: 988K
    the 15 Aug 2025 report24 earlier reportsnormal: 52K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 12 Aug 2025Short interest and volume change

    had 945K shares sold short in the 31 Jul 2025 report, 17× the same report last year.

    Same report last year: 57K; its normal report is 52K.

    See the evidence
    This period
    945K (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    52K
    Typical spread (median absolute deviation)
    12K
    How far from its usual level
    +17.9
    Same report last year
    57K
    History used
    748 days
    2024-07-31: 57K2024-08-15: 20K2024-08-30: 22K2024-09-13: 27K2024-09-30: 30K2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K2025-06-30: 413K2025-07-15: 387K2025-07-31: 945K
    the 31 Jul 2025 report24 earlier reportsnormal: 52K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 26 Jun 2025Short interest and volume change

    had 660K shares sold short in the 13 Jun 2025 report, 20× the same report last year.

    Same report last year: 33K; its normal report is 44K.

    See the evidence
    This period
    660K (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    44K
    Typical spread (median absolute deviation)
    12K
    How far from its usual level
    +12.3
    Same report last year
    33K
    History used
    700 days
    2024-06-14: 33K2024-06-28: 18K2024-07-15: 35K2024-07-31: 57K2024-08-15: 20K2024-08-30: 22K2024-09-13: 27K2024-09-30: 30K2024-10-15: 41K2024-10-31: 44K2024-11-15: 43K2024-11-29: 39K2024-12-13: 62K2024-12-31: 39K2025-01-15: 59K2025-01-31: 53K2025-02-14: 52K2025-02-28: 50K2025-03-14: 52K2025-03-31: 57K2025-04-15: 42K2025-04-30: 175K2025-05-15: 158K2025-05-30: 462K2025-06-13: 660K
    the 13 Jun 2025 report24 earlier reportsnormal: 44K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 6 Jun 2025Filings record

    Delisting notice or listing transfer

  13. 20 May 2025Filings record

    Delisting notice or listing transfer

  14. 24 Apr 2025Filings record

    Registered new securities for sale (S-1)

  15. 22 Apr 2025Filings record

    Registered new securities for sale (S-1)

  16. 13 Dec 2024Filings record

    Registered new securities for sale (S-1)

  17. 5 Dec 2024Filings record

    Private placement of securities (Form D)

  18. 23 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 23 Oct 2024Filings record

    Director or officer change

  20. 17 Jul 2024Filings record

    Director or officer change

  21. 24 May 2024Filings record

    Director or officer change

  22. 15 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 15 May 2024Filings record

    Director or officer change

  24. 19 Apr 2024Filings record

    Delisting notice or listing transfer

  25. 7 Feb 2024Filings record

    Director or officer change

  26. 12 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 12 Dec 2023Filings record

    Director or officer change

  28. 29 Jun 2023Filings record

    Registered new securities for sale (S-1)

  29. 23 Jun 2023Filings record

    Registered new securities for sale (S-1)

  30. 9 Jun 2023Filings record

    Registered new securities for sale (S-1)

  31. 18 May 2023Filings record

    Registered new securities for sale (S-1)

  32. 27 Jan 2023Filings record

    Registered new securities for sale (S-1)

  33. 13 Jan 2023Filings record

    Registered new securities for sale (S-1)

  34. 2 Nov 2022Filings record

    Registered new securities for sale (S-1)

  35. 3 Oct 2022Filings record

    Registered new securities for sale (S-1)

  36. 20 Sep 2022Filings record

    Registered new securities for sale (S-1) (dated 19 Sep 2022)

  37. 16 May 2022Filings record

    Registered new securities for sale (S-1)

  38. 19 Apr 2022Filings record

    Registered new securities for sale (S-1)

  39. 7 Jan 2022Filings record

    Registered new securities for sale (S-1)

  40. 9 Dec 2021Filings record

    Registered new securities for sale (S-1)

Showing the newest 40 of 44 entries; narrow the window or the kind of data to see older ones.

Not listed: 48 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001567264
Ticker
INTS
Domain
intensitytherapeutics.com
Hq location
CT|SHELTON|06484 (1 unverified)
Name
Intensity Therapeutics, Inc.
  • SEC Form 13F institutional holdings126 data points30 Jun 2023 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)79 records28 Oct 2021 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)217 data points31 Dec 2021 to 4 Nov 2026
  • FINRA short interest (twice monthly)239 data points14 Jul 2023 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1706 data points30 Jun 2023 to 20 Nov 2026